Profund Advisors LLC Acquires 1,078 Shares of Axon Enterprise, Inc $AXON

Profund Advisors LLC boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 18.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,834 shares of the biotechnology company’s stock after buying an additional 1,078 shares during the quarter. Profund Advisors LLC’s holdings in Axon Enterprise were worth $5,658,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in AXON. TCTC Holdings LLC grew its stake in Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after buying an additional 24 shares during the last quarter. Banque Transatlantique SA purchased a new stake in shares of Axon Enterprise during the first quarter worth about $31,000. Flaharty Asset Management LLC acquired a new position in shares of Axon Enterprise during the first quarter valued at about $33,000. Hemington Wealth Management raised its position in shares of Axon Enterprise by 70.8% in the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 17 shares during the last quarter. Finally, Whipplewood Advisors LLC boosted its stake in Axon Enterprise by 192.9% in the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after purchasing an additional 27 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In other news, CAO Jennifer H. Mak sold 77 shares of the business’s stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $760.00, for a total transaction of $58,520.00. Following the transaction, the chief accounting officer directly owned 15,003 shares in the company, valued at $11,402,280. The trade was a 0.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua Isner sold 15,919 shares of the stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president directly owned 238,379 shares of the company’s stock, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 49,932 shares of company stock valued at $36,802,716. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Up 2.6%

Shares of Axon Enterprise stock opened at $602.51 on Monday. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 12-month low of $469.24 and a 12-month high of $885.91. The stock has a market cap of $47.54 billion, a price-to-earnings ratio of 148.77, a PEG ratio of 29.49 and a beta of 1.45. The company has a fifty day simple moving average of $719.61 and a 200-day simple moving average of $737.16.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, November 4th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $710.64 million for the quarter, compared to analysts’ expectations of $704.83 million. During the same quarter last year, the business posted $1.45 earnings per share. The business’s revenue was up 30.6% on a year-over-year basis. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Ratings Changes

AXON has been the subject of a number of research reports. Needham & Company LLC reaffirmed a “buy” rating and set a $870.00 price target on shares of Axon Enterprise in a research report on Wednesday, September 24th. Bank of America raised their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. The Goldman Sachs Group decreased their price objective on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a report on Wednesday, November 5th. Finally, Cowen restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $810.71.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.